Follow-The-Filings

Security

Anika Therapeutics Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

8 owners 1 exit max 0.0% (Renaissance Technologies LLC)

owners 8
max % 0.0%
tracked value $26M
qoq A 2 R 5 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Renaissance Technologies LLC 2026 Q1 0.0% Reduce 0.00 pp 502,217 $7M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Reduce 0.00 pp 779,165 $7M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 272,269 $4M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Reduce 0.00 pp 229,796 $3M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 233,808 $2M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 52,062 $755 hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Reduce 0.00 pp 29,229 $424 hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Reduce 0.00 pp 23,931 $347 hist
Israel Englander - Millennium Management LLC exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 26,154 $251 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $166.66M $119.91M $112.82M
Gross profit $103.09M $76M $63.81M
Gross margin * 61.9% 63.4% 56.6%
Net income -$82.67M -$56.38M -$10.88M
Net margin * -49.6% -47.0% -9.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $163.31M $113.65M $103.36M
Total non-current assets * $107.32M $89.09M $86.91M
Total assets $270.63M $202.74M $190.27M
Total current liabilities $31.06M $23.31M $21.91M
Total non-current liabilities
Total equity $212.26M $153.99M $143.46M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$1.79M $5.4M $11.19M
Cash from investing -$5.43M -$8.33M -$401,000
Cash from financing -$6.32M -$12.73M -$10.55M
Net change in cash -$13.46M -$15.71M $322,000

ownership over time

filing count by report period · click a bar for that quarter’s holders